Testosterone

立即咨询

Testosterone

本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。

CAS NO:

58-22-0

包装与价格：

包装	价格(元)
50mg	询价
150mg	询价

化学性质

Storage	Store at -20°C
M.Wt	288.42
Cas No.	58-22-0
Formula	C₁₉H₂₈O₂
Solubility	insoluble in H2O; ≥36.3 mg/mL in EtOH; ≥47.6 mg/mL in DMSO
Chemical Name	(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
Canonical SMILES	O=C1CC[C@]2(C)[C@@]3([H])CC[C@@]4(C)[C@](CC[C@@H]4O)([H])[C@]3([H])CCC2=C1
运输条件	蓝冰运输或根据您的需求运输。
一般建议	为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异，仅做参考。若实验所需浓度过大至产品溶解极限，请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存，请尽快用完。

资料参考

Testosterone, the major androgen in males, acts by binding to the androgen receptor (AR), with an EC50 of 0.66 nM [1].

Testosterone is essential for the maintenance of spermatogenesis by binding to the AR, which is expressed in different cell types of the testis such as Sertoli cells and sperm cells [2]. Testosterone has also been suggested to play a role in mediating biological processes associated with bone metabolism [3].

In vitro incubation with testosterone (0, 2, 4, or 6 ng/mL) decreased the post-thaw acrosome integrity of ram (Ovis aries) sperm (from 68.1 ± 6.3% to 49.6 ± 3.9%) [2]. In RAW264.7 cells stimulated by receptor activator of nuclear factor kappa-Β ligand (RANKL), testosterone (1, 10 and 100 nM) decreased osteoclast formation in a dose-dependent manner, and, at 100 nM, significantly down-regulated the production of tumor necrosis factor-α (TNF-α) [3].

In a double-blind, placebo-controlled 6-week trial involving 74 patients, biweekly testosterone injections (200 mg as the initial dose, increased to 400 mg after 2 weeks), followed by 12 weeks of open-label maintenance treatment, were well tolerated and effective in the short-term treatment of symptoms of clinical hypogonadism in men with symptomatic human immunodeficiency virus illness, restoring libido and energy, alleviating depressed mood, and increasing muscle mass [4].

References:

[1]. Sonneveld E, Jansen H J, Riteco J A, et al. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicological Sciences, 2005, 83(1): 136-148.

[2]. Martínez-Fresneda L, O'Brien E, López Sebastián A, et al. In vitro supplementation of testosterone or prolactin affects spermatozoa freezability in small ruminants. Domestic Animal Endocrinology, 2020, 72: 106372.

[3]. Steffens J P, Coimbra L S, Rossa C Jr, et al. Androgen receptors and experimental bone loss - an in vivo and in vitro study. Bone. 2015, 81: 683-690.

[4]. Rabkin J G, Wagner G J, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Archives of General Psychiatry, 2000, 57(2): 141-156.